phosphorylethanolamine has been researched along with Malignant Melanoma in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mambelli, LI | 1 |
| Teixeira, SF | 1 |
| Jorge, SD | 1 |
| Kawamura, B | 1 |
| Meneguelo, R | 1 |
| Barbuto, JAM | 1 |
| de Azevedo, RA | 1 |
| Ferreira, AK | 1 |
1 other study available for phosphorylethanolamine and Malignant Melanoma
| Article | Year |
|---|---|
Phosphoethanolamine induces caspase-independent cell death by reducing the expression of C-RAF and inhibits tumor growth in human melanoma model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Caspases; Cell Cycle Checkpoints; Cell Mov | 2018 |